About the Authors

Joseph Schober

Roles Conceptualization, Investigation, Supervision, Writing – review & editing

joschob@siue.edu

Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America

Jahnavi Polina

Roles Investigation, Methodology

Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America

Field Walters

Roles Investigation, Methodology

Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America

Nathan Scott

Roles Investigation, Methodology

Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America

Eric Lodholz

Roles Investigation, Methodology

Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America

Albert Crider

Roles Resources

Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America

Karin Sandoval

Roles Data curation, Formal analysis, Writing – original draft, Writing – review & editing

Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America

Ken Witt

Roles Conceptualization, Funding acquisition, Investigation, Resources, Supervision, Writing – original draft, Writing – review & editing

Affiliation Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, United States of America

Competing Interests

Authors K. Witt, A. Crider, and K. Sandoval are co-inventors on patent applications for the development of SSTR4 agonists, through Southern Illinois University Edwardsville (USA patent application No. PCT/US2018/032368; European National Application No. 18798793.8, Japanese Application No. 2019-562574). Ken Witt is CEO of Somatolynk Inc., a company focused on advancement of SST4 agonists. These patent applications and the commercial affiliation with Somatolynk Inc. does not alter our adherence to PLOS ONE policies on sharing data and materials.